PAVmed (PAVM) executive compensation, 2026 proxy

Lishan Aklog, M.D., Chairman of the Board and Chief Executive Officer, was paid $1M in 2025, up 56% from $663,550 the year before.

Filed
April 30, 2026
Annual meeting
June 24, 2026
Pay year
2025
Named executives
4
CEO total pay
$1M+56% vs prior year
CEO pay in equity
6%$64,650 in awards
CEO Salary
$613,000Base salary for fiscal 2025
CEO Bonus
$306,500Bonus paid for fiscal 2025
CEO Stock Awards
$64,650Estimated grant date fair value

How M.D. was paid

$1M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary59%Bonus30%Stock awards6%All other compensation5%

Named executive officers

ExecutiveTotal
Lishan Aklog, M.D.Chairman of the Board and Chief Executive Officer$1,034,850
Dennis M. McGrathPresident and Chief Financial Officer$667,050
Shaun M. O’NeilChief Operating Officer$482,000
Michael A. GordonGeneral Counsel and Secretary$638,250

What changed and why

  • $1MCEO total compensation increased to $1,034,850 in fiscal 2025 from $663,550 in fiscal 2024.
  • $64,650Stock awards granted under the company's 2014 plan were $64,650 for each named executive officer in fiscal 2025.
  • $307KBonuses of $306,500 were awarded to the CEO for fiscal 2025 compared to none in fiscal 2024.
  • $25,200All other compensation for the CEO included $25,200 for transportation reimbursement and $14,400 for club membership fees.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.